In this concise YouTube monologue, Eric Roberts—who emphasizes he is not a peptide expert and has no commercial interest—provides a no‑BS overview of the emerging weight‑loss medication Retatrutide. He reports that clinical trials showed an average 28% body‑weight reduction, surpassing any previously tested drug. Roberts stresses that Retatrutide is not yet FDA‑approved, meaning its composition is unregulated and sourcing the product carries unknown risks. He warns that most users regain the lost weight within a year because the drug suppresses hunger without teaching essential habits such as consistent weight‑lifting, adequate protein and fiber intake, and regular cardio and step counts. While he concedes the drug may be safe for some, he leaves the decision to the viewer, urging that sustainable weight loss ultimately depends on lifestyle changes. He closes by inviting viewers to follow him for more straightforward fat‑loss advice.
